Prevalence of Autism Spectrum Conditions in Mainland China (China SCORE)

University of Cambridge

Status: Unknown

Conditions: Autism Spectrum Conditions/Disorders

Treatments: Behavioral: ADOS/ADI-R/Clinical assessment

Study type: Observational

Funder types: Other

Identifiers

NCT02065193

China SCORE study

Details and patient eligibility

About

The China SCORE study is a prevalence study of Autism Spectrum Conditions (ASC) in 14 regions in mainland China. It will include the following steps:

1. Large population-based screening This study will be conducted in urban areas but not rural areas across mainland China. One city of each region will participate, and in total there will be 14 cities for screening. Within each city, a number of 40 to 60 ordinary primary schools will be randomly selected from the defined region. All the students who are in 1st to 4th grade will asked to participate in order to form a sample of approximately 20,000 students.

   Screening questionnaires The screening pack includes the Chinese CAST, the AQ-Child, the AQ-Adult short version (10 items), and risk factors questionnaire. An information sheet and consent form will be included in the pack as well.

2. Further assessments We expect approximately 5% on the CAST will score positive in ordinary school population. Thus, for a 20,000 sample, we would expect 900 positives (90% response rate). All the screen-positives and a random selected 5% from borderline group will be invited for clinical assessment. The diagnosis of clinical assessment will be divided into three categories: definite ASC, suspected ASC, and non-ASC. Then all the children with clinical assessment results as definite ASC and suspected ASC and a randomly selected 10-20 non-ASC will be invited for research diagnostic assessment using the ADOS and ADI-R, as well as RPM as IQ test. After that, the consensus diagnosis between ADOS/ADI-R assessment and the clinical diagnosis will be the final diagnosis.

3. Case identification in special schools All the children in special schools or training institutes in study region will be asked to fill in the screening pack. The children who do not attend any ordinary or special schools will be identified according to their residential ID in the studied regions. All screen-positives in special education will be assessed using the ADOS and ADI-R. Then those who met the criteria of ASC on ADOS or/and ADI-R will be assessed by psychiatrists and the clinical diagnosis will be the final diagnosis.

If we combine the prevalence of ordinary schools and special schools together, we will get an estimate of the prevalence of ASC in school-population in China. If we combine all the cases identified from schools and from residential records, we will generate an estimate of the prevalence of ASC in the general population in mainland China.

Enrollment: 280,000 estimated patients

Sex: All

Ages: 6 to 11 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All children who are in study region will be recruited for this study.
• All children aged 6-11 years old.

Exclusion criteria

• Children who are not in the study region.
• Children who are not found from ordinary schools, private training centres, public special schools and community household with the help of local residence records will not be included for this study.

Trial design

280,000 participants in 14 patient groups

Beijing group

Treatment:

Behavioral: ADOS/ADI-R/Clinical assessment

Guangdong group

Treatment:

Behavioral: ADOS/ADI-R/Clinical assessment

Shenzhen group

Treatment:

Behavioral: ADOS/ADI-R/Clinical assessment

Shanxi group

Treatment:

Behavioral: ADOS/ADI-R/Clinical assessment

Liaoning group

Treatment:

Behavioral: ADOS/ADI-R/Clinical assessment

Jilin group

Treatment:

Behavioral: ADOS/ADI-R/Clinical assessment

Heilongjiang group

Treatment:

Behavioral: ADOS/ADI-R/Clinical assessment

Jiangsu group

Treatment:

Behavioral: ADOS/ADI-R/Clinical assessment

Zhejiang group

Treatment:

Behavioral: ADOS/ADI-R/Clinical assessment

Fujian group

Treatment:

Behavioral: ADOS/ADI-R/Clinical assessment

Henan group

Treatment:

Behavioral: ADOS/ADI-R/Clinical assessment

Hubei group

Treatment:

Behavioral: ADOS/ADI-R/Clinical assessment

Hunan group

Treatment:

Behavioral: ADOS/ADI-R/Clinical assessment

'Shanxi group

Treatment:

Behavioral: ADOS/ADI-R/Clinical assessment